0001127602-12-007835.txt : 20120224 0001127602-12-007835.hdr.sgml : 20120224 20120224163027 ACCESSION NUMBER: 0001127602-12-007835 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120223 FILED AS OF DATE: 20120224 DATE AS OF CHANGE: 20120224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERSTEIN DAVID L CENTRAL INDEX KEY: 0001242986 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 12638610 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0304 4 2012-02-23 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001242986 BERSTEIN DAVID L C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 Senior VP, Chief IP Officer Common Stock 2012-02-23 4 S 0 4100 15.00 D 198256 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011. /s/Edward M. Fitzgerald, Attorney-in-Fact 2012-02-24